| Valeria Gonzalez, OTD, OTR/L | |
|
200 1st St Sw, Rochester, MN 55905-0001 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Valeria Gonzalez |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720701808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119008251 (Virginia) | Secondary |
| 225X00000X | Occupational Therapist | 107188 (Minnesota) | Primary |
| Provider Name | Jp Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851770598 PECOS PAC ID: 6709192503 Enrollment ID: O20150824001999 |
News Archive
CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced the selection of four sites for clinical testing of its patented QL Care™ Analyzer, a portable diagnostic platform designed to produce test results with central lab-like accuracy in 15 minutes using whole blood.
Queensland researchers have come up with a "highly accurate" melanoma detection online tool that can help diagnose the condition within 90 seconds. The test can predict if a person would get the infection within the next three and a half years.
Electric acoustic stimulation (EAS) combines electric stimulation in the mid- to high-frequency regions with acoustic stimulation in the low-frequency range with the aim to preserve residual low-frequency hearing after cochlear implantation, which together particularly improves speech understanding, pitch discrimination and music appreciation.
Researchers at the Keck School of Medicine of the University of Southern California (USC) have identified a key mechanism that causes chromosomes within blood cells to break - an occurrence that marks the first step in the development of human lymphoma.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Valeria Gonzalez, OTD, OTR/L 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Valeria Gonzalez, OTD, OTR/L 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced the selection of four sites for clinical testing of its patented QL Care™ Analyzer, a portable diagnostic platform designed to produce test results with central lab-like accuracy in 15 minutes using whole blood.
Queensland researchers have come up with a "highly accurate" melanoma detection online tool that can help diagnose the condition within 90 seconds. The test can predict if a person would get the infection within the next three and a half years.
Electric acoustic stimulation (EAS) combines electric stimulation in the mid- to high-frequency regions with acoustic stimulation in the low-frequency range with the aim to preserve residual low-frequency hearing after cochlear implantation, which together particularly improves speech understanding, pitch discrimination and music appreciation.
Researchers at the Keck School of Medicine of the University of Southern California (USC) have identified a key mechanism that causes chromosomes within blood cells to break - an occurrence that marks the first step in the development of human lymphoma.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
› Verified 2 days ago
Amy L Krekelberg, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Danielle Anshus, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Erika Hope Mckeever, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Deborah Engen, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Susan D Hansen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Mary B Clark, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Sara Kathleen Tallman, O.T.D. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |